Maribeth Rouseff1, Ehimen C Aneni2,3,4, Henry Guzman5, Sankalp Das1, Doris Brown5, Chukwuemeka U Osondu3, Erica Spatz6, Brandon Shaffer3, Joann Santiago-Charles5, Teresa Ochoa5, Joseph Mora7, Cynthia Gilliam5, Virginia Lehn5, Shoshana Sherriff5, Thinh H Tran8, Janisse Post3, Emir Veledar3,4, Theodore Feldman3,9, Arthur S Agatston3, Khurram Nasir3,4,9,10,11. 1. Wellness Advantage Administration, Baptist Health South Florida, Miami, Florida, USA. 2. Department of Internal Medicine, Mount Sinai Medical Center, Miami, Florida, USA. 3. Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami, Florida, USA. 4. Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, USA. 5. Employee Health Management, Baptist Health South Florida, Miami, Florida, USA. 6. Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA. 7. Baptist Hospital, Baptist Health South Florida, Miami, Florida, USA. 8. Center for Performance Excellence, Baptist Health South Florida, Miami, Florida, USA. 9. Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA. 10. The Ciccarone Center for Preventive Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. 11. Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, Florida, USA.
Abstract
OBJECTIVE: This study details 6- and 12-month cardio-metabolic outcomes of an intense 12-week workplace lifestyle intervention program, the My Unlimited Potential (MyUP), conducted in a large healthcare organization. METHODS: This study was conducted among 230 employees of Baptist Health South Florida with high cardiovascular disease (CVD) risk. Employees were considered at high risk and eligible for the study if they had two or more of the following cardio-metabolic risk factors: total cholesterol ≥ 200 mg/dl, systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, hemoglobin A1C (HbA1c) ≥ 6.5%, body mass index (BMI) ≥ 30 kg/m(2) . RESULTS: At the end of 12 weeks, there was significant reduction in the mean BMI, SBP and DBP, serum lipids, and HbA1c among persons with diabetes. At 1 year, there was significant decline in the mean BMI, SBP and DBP, HbA1c, and high-sensitivity C-reactive protein, and in the prevalence of poor BP control, BMI ≥ 35 kg/m(2) , and abnormal HbA1c among all persons and those with diabetes. CONCLUSIONS: This intensive 12-week lifestyle change program was successful at improving cardio-metabolic risk factors at 1 year. This study provides a template for other workplace programs aimed at improving CVD risk in high-risk employees.
OBJECTIVE: This study details 6- and 12-month cardio-metabolic outcomes of an intense 12-week workplace lifestyle intervention program, the My Unlimited Potential (MyUP), conducted in a large healthcare organization. METHODS: This study was conducted among 230 employees of Baptist Health South Florida with high cardiovascular disease (CVD) risk. Employees were considered at high risk and eligible for the study if they had two or more of the following cardio-metabolic risk factors: total cholesterol ≥ 200 mg/dl, systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg, hemoglobin A1C (HbA1c) ≥ 6.5%, body mass index (BMI) ≥ 30 kg/m(2) . RESULTS: At the end of 12 weeks, there was significant reduction in the mean BMI, SBP and DBP, serum lipids, and HbA1c among persons with diabetes. At 1 year, there was significant decline in the mean BMI, SBP and DBP, HbA1c, and high-sensitivity C-reactive protein, and in the prevalence of poor BP control, BMI ≥ 35 kg/m(2) , and abnormal HbA1c among all persons and those with diabetes. CONCLUSIONS: This intensive 12-week lifestyle change program was successful at improving cardio-metabolic risk factors at 1 year. This study provides a template for other workplace programs aimed at improving CVD risk in high-risk employees.